← brief for 2026-10-24 · Slowing decline

Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy

Article No results yet Peer reviewed

Key takeaways

This article explains how heart, kidney, and metabolic problems are linked. It discusses how certain drugs might help this group of conditions. It is a review of existing science, not a new trial with patient results.

Who did this work

Fengzhao Liu (Xiyuan Hospital) · Zihan Xu (Xiyuan Hospital) · Wenru Wang (Xiyuan Hospital) · Junwei Gao (Zhejiang Chinese Medical University) · Changgeng FU (Xiyuan Hospital) · Peng Liu (Xiyuan Hospital)

Source

Article · OpenAlex, CKD works · 2026-10-23
https://doi.org/10.3389/fcell.2026.1996288